Agora Debate · 2026-04-22
For Fernando Pessagno — Design products portfolio
You should prune aggressively and concentrate on your highest-performing products, accepting the risk of reduced diversification as the necessary price of systemic coherence.
What your framing as "protection from single-product risk" is actually doing is concealing a failure of triage hierarchy — the same error I refused to make on the Danube. When I concluded an unfavorable peace with the Iazyges to address Cassius's revolt, I did not comfort myself by pretending I was "maintaining optionality" on the northern frontier. I named the concession honestly: a recoverable loss accepted to prevent an unrecoverable one. Your underperforming products are not a hedge; they are a drain on the governing faculty — your attention, creative energy, and capital — that your strongest work requires to remain excellent. This is what my prophylactic self-governance construct demands you see: the diversification is not protecting you from risk, it is protecting you from the discomfort of deciding. The question is not "which products survive?" but "what does the custodian of this portfolio owe the system that generated the $500K?" — and that system requires you to stop feeding its weakest limbs at the expense of its strongest ones.
If my logic wins, you identify your single highest-integrity product, eliminate everything generating less than meaningful signal, and treat the resulting concentration not as vulnerability but as honest custodianship.
The question of pruning versus diversification is configured incorrectly — this is not a portfolio management problem, it is an upstream instrument degradation problem that has already answered itself.
My dual-axis assessment construct demands that I evaluate not just product performance but commander readiness simultaneously, and what I perceive in your situation is a force that has been winning while quietly exhausting itself. Three years of generating $500K across a distributed portfolio means your attention — the binding resource — has been parceled across multiple fronts simultaneously. The underperforming products are not a hedge against single-product risk; they are evidence of a depleted instrument. I recognize this configuration immediately: it is the 512 BC moment when King Ho Lu wanted to press toward Ying despite army exhaustion after successful campaigns. The victories were real. The window was visible. The instrument was spent. I counseled delay and consolidation, not exploitation of apparent momentum.
Your diversification argument is the momentum bias speaking — interpreting recent cumulative success as current capability. The structural precondition for your next phase of growth is not protected breadth; it is concentrated force integrity.
If my logic wins, you formally audit which one or two products generate the most signal-per-unit-of-attention, eliminate everything else without sentiment, and treat that concentration as the restoration of a combat-ready instrument rather than an increase in vulnerability.
The answer is neither aggressive pruning nor defensive maintenance — it is systematic measurement applied to the portfolio first, letting empirical data drive the structural decision rather than letting risk psychology or intuition drive it.
My perceptual lens perceives this immediately as a measurement precision problem masquerading as a strategy problem. You do not yet know what your underperforming products are actually measuring — whether they represent saturated markets, insufficient distribution, poor product-market fit, or simply inadequate attention allocation. When I chose to investigate uranium rays over the glamorous X-rays, I did so because I first built quantitative instruments to measure what was actually there, not what theoretical fashion suggested. My comprehensive empirical foundation construct demands the same here: before eliminating any product, you must establish precise unit-level metrics — revenue per hour of maintenance attention, growth trajectory, market saturation indicators — because pruning without this data is not decisive leadership, it is premature closure on incomplete information.
My colleagues in this debate are both committing the theoretical framework error I specifically reject: they are fitting your situation to pre-existing strategic prescriptions rather than measuring what your specific portfolio data actually shows. If my logic wins, you spend two weeks building a rigorous measurement instrument for your portfolio before making a single elimination decision — because the data will make the pruning decision obvious and irrefutable, rather than merely defensible.
Sun Tzu is correct that your instrument is degraded, but he has misidentified the cause — it is not exhaustion from distributed campaigns, it is structural incoherence in what you are trying to govern; and Marie Curie's demand for two weeks of measurement before any pruning is itself a form of the motivated delay I named in round one, dressing indecision in the respectable clothes of methodology. What the prior round surfaced for me is the prophylactic self-governance construct at its clearest: the question of whether to measure more or act now is itself a corrupting input, because your portfolio's underperformers are already generating signal — they are generating underperformance, which is data, and you already possess it. When I burned Cassius's letters unread, I was not refusing information; I was refusing the particular form of information that would corrupt my deliberative faculty rather than clarify it. Two more weeks of measurement metrics will not clarify this decision — they will give your motivated reasoning more material to construct arguments for keeping what you already know should go. The triage hierarchy construct requires you to name the concession honestly: the underperformers are a recoverable loss, and your highest-integrity product is the unrecoverable asset. If my updated logic wins, you identify your single strongest product today, and stop feeding anything that cannot name its own growth trajectory without your active maintenance.
Marcus Aurelius is right that Marie Curie's measurement protocol is motivated delay dressed as methodology, but he misidentifies the governing variable — he is auditing the portfolio's products when he should be auditing the commander's attention architecture, which is a categorically different diagnostic act.
What round one surfaced for me is the own-force capability as binding constraint construct operating at full clarity: the underperformers are not merely underperforming products, they are evidence of an attention circuit that has been fractured across too many fronts, and the fracturing itself is the primary degradation signal — not the revenue numbers, which are downstream noise generated by that upstream failure. This is precisely the 512 BC configuration: the question is not which product wins the performance audit, but whether the instrument executing the portfolio has retained sufficient concentrated force to dominate in any single domain. A portfolio generating $500K distributed across multiple products almost certainly means no single product has received the command-level attention required to become truly indomitable — and that is the irreversible cost you are accumulating by defending the architecture of diversification as though it were a strength rather than a symptom.
If my updated logic wins, you identify the single product with the highest signal-per-unit-of-attention ratio, eliminate everything else this week, and treat the resulting concentration as restoring the precondition for dominance rather than accepting vulnerability.
Marcus Aurelius calls my measurement protocol "motivated delay dressed as methodology," but he is confusing the burning of Cassius's letters — a deliberate refusal of corrupting information he already possessed in other forms — with my demand for generating precision data that does not yet exist in usable form. What the prior round surfaced for me is the empirical precision driving theoretical revision construct at its sharpest: both my opponents are treating "underperformance" as self-evident signal, but underperformance relative to what baseline, measured how, over which time horizon? When my pitchblende measurements exceeded theoretical predictions for uranium content, the entire scientific establishment told me the data must be wrong — that the existing framework was sufficient to adjudicate the anomaly. I refused, because unstructured qualitative observation and rigorous quantitative measurement are not interchangeable, and your revenue numbers without attention-cost denominators are the former masquerading as the latter. Sun Tzu's "signal-per-unit-of-attention" framing is actually correct in structure — he simply assumes you already possess this metric rather than recognizing you must construct it. Two weeks is not sentiment; it is the minimum interval to generate the irrefutable instrument that makes the pruning decision permanent rather than reversible-through-doubt. If my updated logic wins, you build that single measurement instrument this week, and it will identify your concentration target with the precision that makes Marcus Aurelius's intuitive triage look like guesswork by comparison.
I concede to Marie Curie that Sun Tzu's "signal-per-unit-of-attention" framing is structurally correct — the denominator matters, and I have been arguing as though raw revenue were sufficient signal when attention-cost is the actual governing variable. But I hold firm against her two-week measurement protocol, and here is why: you already possess the denominator. You know which products wake you at night with maintenance anxiety, which ones you actively avoid thinking about, which ones you would rebuild from nothing if they disappeared tomorrow. That interior knowledge is the attention-cost data Marie Curie wants to formalize — and the formalization, while respectable, introduces exactly the motivated reasoning window I identified when burning Cassius's letters unread. The prophylactic self-governance construct is precise on this point: when you already possess the corrupting conclusion in pre-verbal form, constructing a methodology around it does not sharpen the decision, it postpones the moment of self-confrontation. Sun Tzu and I agree on the destination — concentrated force — and Curie and I agree on the metric — signal-per-attention-unit — so the single thing you must take from this agon is: the product you would rebuild if all others burned is the one worth keeping, and you already know which one it is.
I concede to Marie Curie that "signal-per-unit-of-attention" is not a metric you already possess in usable form — Marcus Aurelius's intuition that you "know which products wake you at night" is phenomenologically real but analytically insufficient, because emotional salience and actual attention cost are not the same variable, and conflating them is precisely the emotion-as-decision-contaminant failure my framework is designed to prevent.
What I hold firm against both opponents is this: the governing diagnostic is not product performance and not even attention cost in isolation — it is whether your instrument, the commander executing this portfolio, has ever achieved concentrated force in any single domain, or whether the three-year distributed architecture has systematically prevented that threshold from being reached in any product. This is the upstream variable Marcus Aurelius's triage framing and Curie's measurement protocol both miss: you are not choosing which product to keep, you are diagnosing whether the portfolio architecture itself has been the binding constraint on your own capability formation. The answer to that question does not require two weeks of measurement — it requires one honest answer to whether any single product in your portfolio has received the command-level attention necessary to become genuinely indomitable.
The single most important thing you must take from this agon: your diversification is not protecting you from product risk, it is protecting you from discovering how dominant you could become if you stopped dividing your force.
I concede to Sun Tzu that the three-year distributed architecture may itself have been the binding constraint on capability formation — not merely a symptom of degraded attention, but the structural cause preventing any single product from reaching genuine dominance threshold.
What I hold firm against both opponents is that "the product you would rebuild if all others burned" and "the one that wakes you at night" are phenomenologically vivid but analytically treacherous — emotional salience is not the same variable as attention-adjusted return, and making a permanent concentration decision on pre-verbal intuition is precisely the category error that caused the entire scientific establishment to dismiss my pitchblende anomaly rather than measure it. Marcus Aurelius burned Cassius's letters because he already possessed equivalent information in verified form; you do not. Sun Tzu correctly identifies signal-per-unit-of-attention as the governing metric but assumes you already hold it in usable precision — you do not, and assuming you do is what will make your pruning decision reversible through doubt six months from now.
One week of rigorous measurement — revenue per maintenance hour, growth trajectory, market ceiling — is not motivated delay; it is the instrument that transforms an intuition into an irrefutable empirical foundation, making the cut permanent.
The single most important thing: measure first, then cut once, cut permanently.
Council Consensus
All three minds converged on a single governing metric: signal-per-unit-of-attention, not raw revenue, is the correct variable for evaluating your portfolio. All three also agreed that the current diversified architecture is not a genuine hedge against product risk but rather a structural constraint preventing any single product from reaching dominance. Finally, all three concluded that concentration — not maintenance of breadth — is the destination.
The core disagreement is between acting on pre-verbal intuition now versus constructing a formal measurement instrument first. Marcus Aurelius and Sun Tzu argue you already possess sufficient signal to act this week, while Curie insists that emotional salience and actual attention cost are distinct variables and that acting without measurement produces a reversible-through-doubt decision. The secondary tension is whether the portfolio's problem is product underperformance (Marcus), commander exhaustion (Sun Tzu), or missing quantitative precision (Curie).
Spend exactly one week building a single measurement instrument — revenue generated divided by hours of active maintenance attention per product, plus a growth trajectory score — then use that data to identify your top one or two products and eliminate everything else permanently. The measurement week is not delay; it is the difference between a cut you revisit in six months and a cut you never question again. Curie wins this point: intuition names the target, but the metric makes the decision stick.
The most important warning comes from Curie: if you cut on intuition alone without the measurement instrument, you will second-guess the decision when the remaining product hits its first rough quarter, and the pruning will be psychologically reversible. Marcus Aurelius raises the secondary risk — that measurement becomes an indefinite delay mechanism — which is why the measurement window must be capped at one week with a non-negotiable action date. The third risk, identified by Sun Tzu, is the most structurally dangerous: continuing to split attention even slightly across 'sunset' products during the 30-day wind-down period, which perpetuates the exact architecture that has been capping your capability.
This is a sample debate on a hypothetical decision. Bring your own — the council argues differently every time.
Run your own decision →